Literature DB >> 27034401

HLA-DQ Mismatching: Mounting Evidence for a Role in Kidney Transplant Rejection.

Nagaraju Sarabu1, Donald E Hricik2.   

Abstract

Keywords:  Graft Rejection; HLA-DQ Antigens; Kidney Diseases; acute allograft rejection; human genetics; humans; kidney transplantation

Mesh：

Substances：

Year:  2016        PMID： 27034401      PMCID： PMC4858473          DOI： 10.2215/CJN.02970316

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  14 in total

1.  HLA typing by direct DNA sequencing.

Authors:  Linda K Smith
Journal:  Methods Mol Biol       Date:  2012

Review 2.  HLA typing by SSO and SSP methods.

Authors:  Heather Dunckley
Journal:  Methods Mol Biol       Date:  2012

3.  De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.

Authors:  Michelle Willicombe; Paul Brookes; Ruhena Sergeant; Eva Santos-Nunez; Corinna Steggar; Jack Galliford; Adam McLean; Terence H Cook; Tom Cairns; Candice Roufosse; David Taube
Journal:  Transplantation       Date:  2012-07-27       Impact factor: 4.939

4.  Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Authors:  Donald E Hricik; Richard N Formica; Peter Nickerson; David Rush; Robert L Fairchild; Emilio D Poggio; Ian W Gibson; Chris Wiebe; Kathryn Tinckam; Suphamai Bunnapradist; Milagros Samaniego-Picota; Daniel C Brennan; Bernd Schröppel; Osama Gaber; Brian Armstrong; David Ikle; Helena Diop; Nancy D Bridges; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

Review 5.  HLA compatibility and organ transplant survival. Collaborative Transplant Study.

Authors:  G Opelz; T Wujciak; B Döhler; S Scherer; J Mytilineos
Journal:  Rev Immunogenet       Date:  1999

6.  HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.

Authors:  R Sapir-Pichhadze; K Tinckam; K Quach; A G Logan; A Laupacis; R John; J Beyene; S J Kim
Journal:  Am J Transplant       Date:  2014-12-17       Impact factor: 8.086

7.  Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.

Authors:  C Wiebe; D Pochinco; T D Blydt-Hansen; J Ho; P E Birk; M Karpinski; A Goldberg; L J Storsley; I W Gibson; D N Rush; P W Nickerson
Journal:  Am J Transplant       Date:  2013-10-25       Impact factor: 8.086

8.  DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.

Authors:  Augusto Tagliamacco; Michela Cioni; Patrizia Comoli; Miriam Ramondetta; Caterina Brambilla; Antonella Trivelli; Alberto Magnasco; Roberta Biticchi; Iris Fontana; Pietro Dulbecco; Domenico Palombo; Catherine Klersy; Gian Marco Ghiggeri; Fabrizio Ginevri; Massimo Cardillo; Arcangelo Nocera
Journal:  Transpl Int       Date:  2014-04-25       Impact factor: 3.782

9.  Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

Authors:  F Ginevri; A Nocera; P Comoli; A Innocente; M Cioni; A Parodi; I Fontana; A Magnasco; A Nocco; A Tagliamacco; A Sementa; P Ceriolo; L Ghio; M Zecca; M Cardillo; G Garibotto; G M Ghiggeri; F Poli
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

10.  New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.

Authors:  Ajay K Israni; Nicholas Salkowski; Sally Gustafson; Jon J Snyder; John J Friedewald; Richard N Formica; Xinyue Wang; Eugene Shteyn; Wida Cherikh; Darren Stewart; Ciara J Samana; Adrine Chung; Allyson Hart; Bertram L Kasiske
Journal:  J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 10.121
View more
  1 in total

Review 1.  Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.

Authors:  Tilahun Alelign; Momina M Ahmed; Kidist Bobosha; Yewondwossen Tadesse; Rawleigh Howe; Beyene Petros
Journal:  J Immunol Res       Date:  2018-03-05       Impact factor: 4.818
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.